Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia

Liu,Bei; Li,Li-Jun; Gong,Xia; Zhang,Wei; Zhang,Hui; Zhao,Li

doi:10.3892/ol.2018.8095

Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia

Authors:
- Bei Liu
- Li-Jun Li
- Xia Gong
- Wei Zhang
- Hui Zhang
- Li Zhao
View Affiliations

Affiliations: The First Clinical Medical College of Lanzhou University, The First Affiliated Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China, Department of Special Medicine, The First Affiliated Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China, Central Laboratory, The First Affiliated Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China
Published online on: February 21, 2018 https://doi.org/10.3892/ol.2018.8095
Pages: 6671-6677

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chemotherapy failure remains a challenge when treating patients with acute myeloid leukemia (AML), who often suffer from persistent or relapsed disease. The multidrug resistance (MDR) mediated by efflux transporters of the ATP binding cassette (ABC) superfamily is a major obstacle for successful chemotherapy. The present study aimed to elucidate whether the expression of ABC transporters was associated with prognostic factors and responses to chemotherapy in patients with AML, with particular focus on whether co-expression of multiple ABC transporters resulted in a worse prognosis. In the present study, the mRNA expression levels of ABC transporters ABCB1, ABCB4, ABCC1, ABCC4 and ABCG2 in bone marrow (BM) mononuclear cell (MNC) samples from 96 de novo patients with AML and in the peripheral blood (PB) MNC samples from 22 normal individuals were investigated using reverse transcription-quantitative polymerase chain reaction analysis. It was revealed that ABCB1, ABCC1, ABCC4 and ABCG2 were expressed at higher levels in patients with AML compared with normal individuals, whereas ABCB4 had a lower expression level. The expression of ABCB4 in patients with AML was significantly lower than in normal individuals (P<0.001). Patients risk status was associated with ABCB1 (P=0.037), ABCC1 (P=0.047), ABCC4 (P=0.015) and ABCG2 (P=0.027). The 4 genes were expressed a significantly higher levels in the poor response group compared with the good response group (ABCB1, P=0.014; ABCC1, P=0.021; ABCC4, P=0.005; ABCG2, P=0.009). The overexpression of the 4 ABC transporters and the complete remission rate were inversely correlated (P<0.001). These results suggest that the co-expression of multiple ABC transporters may contribute to a worse prognosis in AML.

View Figures

View References

1	Zöchbauer S, Gsur A, Brunner R, Kyrle PA, Lechner K and Pirker R: P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. Leukemia. 8:974–977. 1994.PubMed/NCBI
2	Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, Corre E, Lapusan S, Lallemand JY, Marie JP, et al: ATP binding cassette transporters associated with chemoresistance: Transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients. Haematologica. 96:1293–1301. 2011. View Article : Google Scholar : PubMed/NCBI
3	Januchowski R, Wojtowicz K, Andrzejewska M and Zabel M: Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines. Biomed Pharmacother. 68:111–117. 2014. View Article : Google Scholar : PubMed/NCBI
4	Matthews C, Catherwood MA, Larkin AM, Clynes M, Morris TC and Alexander HD: MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia. Leuk Lymphoma. 47:2308–2313. 2006. View Article : Google Scholar : PubMed/NCBI
5	Drain S, Catherwood MA and Alexander HD: Multidrug resistance in the chronic lymphoproliferative disorders. Leuk Lymphoma. 51:1793–1804. 2010. View Article : Google Scholar : PubMed/NCBI
6	Liu B, Zhao L, Ma HZ, Zhang W and Jin Y: Knockdown of MRP4 by lentivirus-mediated siRNA improves sensitivity to adriamycin in adriamycin-resistant acute myeloid leukemia cells. Chin Sci Bull. 57:90–97. 2012. View Article : Google Scholar
7	Yuan X, Koehn J and Hogge DE: Identification of prognostic subgroups among acute myeloid leukemia patients with intermediate risk cytogenetics using a flow-cytometry-based assessment of ABC-transporter function. Leuk Res. 39:689–695. 2015. View Article : Google Scholar : PubMed/NCBI
8	Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR and Bertino JR: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA. 86:pp. 695–698. 1989; View Article : Google Scholar : PubMed/NCBI
9	Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L and Li J: Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 370:153–164. 2016. View Article : Google Scholar : PubMed/NCBI
10	Cianfriglia M, Mallano A, Ascione A and Dupuis ML: Multidrug transporter proteins and cellular factors involved in free and mAb linked calicheamicin-gamma1 (gentuzumab ozogamicin, GO) resistance and in the selection of GO resistant variants of the HL60 AML cell line. Int J Oncol. 36:1513–1520. 2010. View Article : Google Scholar : PubMed/NCBI
11	Schinkel AH and Jonker JW: Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview. Adv Drug Deliv Rev. 55:3–29. 2003. View Article : Google Scholar : PubMed/NCBI
12	Farawela HM, Khorshied MM, Kassem NM, Kassem HA and Zawam HM: The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: An egyptian study. J Cancer Res Clin Oncol. 140:1323–1330. 2014. View Article : Google Scholar : PubMed/NCBI
13	Chauhan PS, Bhushan B, Singh LC, Mishra AK, Saluja S, Mittal V, Gupta DK and Kapur S: Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: Response to induction chemotherapy. Exp Mol Pathol. 92:44–49. 2012. View Article : Google Scholar : PubMed/NCBI
14	Kim HP, Bernard L, Berkowitz J, Nitta J and Hogge DE: Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia. Cytometry B Clin Cytom. 82:283–294. 2012. View Article : Google Scholar : PubMed/NCBI
15	Varatharajan S, Abraham A, Karathedath S, Ganesan S, Lakshmi KM, Arthur N, Srivastava VM, George B, Srivastava A, Mathews V and Balasubramanian P: ATP-binding casette transporter expression in acute myeloid leukemia: Association with in vitro cytotoxicity and prognostic markers. Pharmacogenomics. 18:235–244. 2017. View Article : Google Scholar : PubMed/NCBI
16	Guo Y, Köck K, Ritter CA, Chen ZS, Grube M, Jedlitschky G, Illmer T, Ayres M, Beck JF, Siegmund W, et al: Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: Relation to long-term survival. Clin Cancer Res. 15:1762–1769. 2009. View Article : Google Scholar : PubMed/NCBI
17	Hauswald S, Duque-Afonso J, Wagner MM, Schertl FM, Lübbert M, Peschel C, Keller U and Licht T: Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. Clin Cancer Res. 15:3705–3715. 2009. View Article : Google Scholar : PubMed/NCBI
18	Bartholomae S, Gruhn B, Debatin KM, Zimmermann M, Creutzig U, Reinhardt D and Steinbach D: Coexpression of multiple ABC-transporters is strongly associated with treatment response in childhood acute myeloid leukemia. Pediatr Blood Cancer. 63:242–247. 2016. View Article : Google Scholar : PubMed/NCBI
19	Liu Y, Cui P, Chen J and Li W: Isolation and phenotypic characterization of side population cells in oral squamous cell carcinoma. Mol Med Rep. 11:3642–3646. 2015. View Article : Google Scholar : PubMed/NCBI
20	Kiehl S, Herkt SC, Richter AM, Fuhrmann L, El-Nikhely N, Seeger W, Savai R and Dammann RH: ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth. Sci Rep. 4:68992014. View Article : Google Scholar : PubMed/NCBI
21	Zinzi L, Contino M, Cantore M, Capparelli E, Leopoldo M and Colabufo NA: ABC transporters in CSCs membranes as a novel target for treating tumor relapse. Front Pharmacol. 5:1632014. View Article : Google Scholar : PubMed/NCBI
22	Kampen KR, Ter Elst A, Mahmud H, Scherpen FJ, Diks SH, Peppelenbosch MP, de Haas V, Guryev V and de Bont ES: Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML. Leukemia. 28:589–599. 2014. View Article : Google Scholar : PubMed/NCBI
23	Chen Y, Bieber MM and Teng NN: Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer. Mol Carcinog. 53:625–634. 2014.PubMed/NCBI
24	Lin CC, Hsu YC, Li YH, Kuo YY, Hou HA, Lan KH, Chen TC, Tzeng YS, Kuo YY, Kao CJ, et al: Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia. Haematologica. 102:1044–1053. 2017. View Article : Google Scholar : PubMed/NCBI
25	Alharbi RA, Pettengell R, Pandha HS and Morgan R: The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia. 27:1000–1008. 2013. View Article : Google Scholar : PubMed/NCBI